---
title: “Efficacy of Ivermectin Treatment on Disease Progression Among Adults With
  Mild to Moderate COVID-19 and Comorbidities The I-TECH Randomized Clinical Trial”
date: '2022-02-19'
linkTitle: https://statmodeling.stat.columbia.edu/2022/02/18/efficacy-of-ivermectin-treatment-on-disease-progression-among-adults-with-mild-to-moderate-covid-19-and-comorbidities-the-i-tech-randomized-clinical-trial/
source: Statistical Modeling, Causal Inference, and Social Science
description: 'Bob Young writes: JAMA paper published today. Do you see any problems
  with their conclusion? From the abstract: The Ivermectin Treatment Efficacy in COVID-19
  High-Risk Patients (I-TECH) study was an open-label randomized clinical trial conducted
  at 20 public hospitals and &#8230; <a href="https://statmodeling.stat.columbia.edu/2022/02/18/efficacy-of-ivermectin-treatment-on-disease-progression-among-adults-with-mild-to-moderate-covid-19-and-comorbidities-the-i-tech-randomized-clinical-trial/">Continue
  reading <span class="meta-nav">&#8594;</span></a> ...'
disable_comments: true
---
Bob Young writes: JAMA paper published today. Do you see any problems with their conclusion? From the abstract: The Ivermectin Treatment Efficacy in COVID-19 High-Risk Patients (I-TECH) study was an open-label randomized clinical trial conducted at 20 public hospitals and &#8230; <a href="https://statmodeling.stat.columbia.edu/2022/02/18/efficacy-of-ivermectin-treatment-on-disease-progression-among-adults-with-mild-to-moderate-covid-19-and-comorbidities-the-i-tech-randomized-clinical-trial/">Continue reading <span class="meta-nav">&#8594;</span></a> ...